School of Biomedical Sciences
The University of Edinburgh Skip Navigation The University of Edinburgh School of Biomedical Sciences
Centre for Cognitive and Neural Systems


Dr Jeremy Hall

   

Division of Psychiatry
School of Molecular and Clinical Medicine
University of Edinburgh
Royal Edinburgh Hospital
Edinburgh
EH10 5HF

Telephone: +44 131 537 6313
Fax: +44 131 537 6291
Email: Jeremy.Hall@ed.ac.uk

 
top of page

Research focus

My research currently focuses on the neural basis of memory and emotion dysfunction in schizophrenia, and the genetic factors influencing such impairments. The overall strategy of this work is to develop sensitive cognitive tests of emotional and mnemonic function and to use these in the functional neuroimaging environment. In addition I am interested in how genetic factors, specifically those associated with increased risk for major mental illness, impact on the neural basis of these behaviours.

I have particularly focused on task testing medial temporal lobe function. On this basis I have undertaken tests of social, emotional and memory function in patients with schizophrenia. Using such tasks I have been able to demonstrate impairments in patients with schizophrenia that are strongly suggestive of dysfunction in the medial temporal lobe in tests of facial emotion recognition, social judgment and emotional memory (Hall, et al 2007, Neuropsychologia 25;45(6):1152-9; Hall, et al 2004, Br J Psychiatry 185:169-70).

In a parallel line of investigation I have been working on the impact of schizophrenia susceptibility genes on brain structure and function using fMRI. Recently we have been able to demonstrate that the schizophrenia susceptibility gene neuregulin 1 influences risk of development of psychosis using data from the Edinburgh High Risk Study (Hall, et al 2006, Nat Neurosci 9(12):1477-8). We have additionally shown that genetic variation in this gene also authors both temporal lobe and frontal lobe function as assessed by fMRI. Furthermore the same genetic variation was also associated with impairments in IQ. In collaboration with my colleague, Dr Andrew McIntosh, we have followed up this work and recently demonstrated that the same genetic variant in neuregulin 1 is associated with abnormalities in white matter density and integrity suggesting that this may be one mechanism through which neuregulin 1 contributes to the pathological deficits seen in schizophrenia (McIntosh, et al 2007, Molecular Psychiatry, In Press).

top of page









 

 

 

 

 

 

 

 

 

 

 

 

 

 

______________________________________________

Published by Marianne Eastwood (m.eastwood@ed.ac.uk)
© 2007 The University of Edinburgh

August 2007